Nuzenio

Crispr Therapeutics

Crispr Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 06:26:15 GMTCRISPR Therapeutics (CRSP) Earnings Drew Fresh Interest, Is The Stock Below Fair Value? - simplywall.st
Sat, 08 Aug 2026 05:48:57 GMTCRISPR Therapeutics (NASDAQ:CRSP) Rating Increased to Hold at Wall Street Zen - MarketBeat
Fri, 07 Aug 2026 13:40:06 GMTWill Phase III lonvo-z Data and Resumed ATTR Program Change Intellia Therapeutics' (NTLA) Narrative - simplywall.st
Fri, 07 Aug 2026 12:02:00 GMTGoldman Sachs Keeps Their Hold Rating on Crispr Therapeutics AG (CRSP) - The Globe and Mail
Fri, 07 Aug 2026 08:22:56 GMTCalifornia State Teachers Retirement System Increases Stock Position in CRISPR Therapeutics AG $CRSP - MarketBeat
Fri, 07 Aug 2026 08:20:29 GMTBrave Asset Management Inc. Cuts Stake in CRISPR Therapeutics AG $CRSP - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Crispr Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.